Corelaţii clinice,imunohistochimice şi morfopatologice în unele tumori de ovar Coordonator ştiinţific:Prof.Dr.Zenovia Florentina Pricop __________________________________________________Doctorand:Ioana Buda 75. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA 1996; 65:5-27. 76. Parker, D., Bradley, C., Bogle, S. M., Lay, J., Masood, M., Hancock, A. K. et al. (1994). Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. Br. J. Obstet. Gynaecol. 101(10), 888– 893. 77. Pautier P, Lhomme C, Culine S, et al. Adult granulosa cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer 1997;7:58–65 78. Pearl, M. L., Yashar, C. M., Johnston, C. M., Reynolds, R. K., and Roberts, J. A. (1994). Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol. Gynecol. Oncol. 53(3), 339–343. 79. Powell JL, Otis CN. Management of advanced juvenile granulosa cell tumor of the ovary. Gynecol Oncol. Feb 1997;64(2):282-4. 80. Prat J., Matias-Guiu X., Barreto J., Simultaneous carcinoma involving the endometrium and the ovary: a clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases, Cancer, 1991, 68: 2455- 2459 81. Pricop M., Oncologie ginecologică clinică, Editura Polirom, Iaşi, 2000 82. Pricop M.,Chirurgie ginecologica.Puncte de vedere,Institutul European,2006 125-133 83. Pricop M.Curs de obstetrica si ginecologie ,Institutul European 2001,Volumul 2-Ginecologia 267-296 84. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575–80. 85. Rubin SC, Sabbatini P, Randall ME. Ovarian Cancer. In: Pazdur R, Hoskins WH, Wagman L, eds. Cancer Management: A Multidisciplinary Approach. 4th ed. Mellville, NY: PRR Incorporated; 2000:. 409-28. 86. Sadler T.W,Embriologie medicala,Callisto ,2007 87. Sakaki M, Hirokawa M, Horiguchi H, Wakatsuki S, Sano T, Izumi Y: Ovarian fibrothecoma with massive edema. J Med Invest 2000, 47:148-150 88. Skirnisdóttir I, Seidal T, Gerdin E, sorbe B – The prognostic importance of p53, Bcl-2, and Bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotHERapy, Int J Gynecol Cancer, 2002, 12(3):265-276 89. Slamon D J. Godolphin W, Jones LA el al. Studies of the HER-2, neu proto-oncogene in human breast and ovarian cancer. Science 1989: 244:707 712 90. Slotman BJ & Rao BR 1988 Ovarian cancer (review): etiology, diagnosis, prognosis, surgery, radiotHERapy, chemotHERapy and endocrine tHERapy. Anticancer Research 8 417–434. Endocrine-Related Cancer (2000) 7 85–93 91. Surcel I.V.-Obstetrica si ginecologie,Dacia ,2005,925-939 92. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM, 2006b. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 174 cases. Am J Surg Pathol. 30(9):1130-1139).- 93. Vermorken JB, Parmar MKB, Brady MF – Clinical trials in ovarian carcinoma: study methodology, Ann Oncol, 2005;16:20-29 94. Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, et al. Expression of the vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasm: correlation with clinicopathology and patients survival, and analysis of serum VEGF levels. Br J Cancer 1997;76:1221–7. 80
Corelaţii clinice,imunohistochimice şi morfopatologice în unele tumori de ovar Coordonator ştiinţific:Prof.Dr.Zenovia Florentina Pricop __________________________________________________Doctorand:Ioana Buda 95. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol. Aug 1984;8(8):575-96. 96. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of LMPtumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 19(10): 2658-64, May 2001. 97. Zanoschi Ch.,Tratat de anatomie ginecologica,Scripta Manent 2004 81
- Page 1 and 2:
Corelaţii clinice,imunohistochimic
- Page 3 and 4:
Corelaţii clinice,imunohistochimic
- Page 5 and 6:
Corelaţii clinice,imunohistochimic
- Page 7 and 8:
Corelaţii clinice,imunohistochimic
- Page 9 and 10:
Corelaţii clinice,imunohistochimic
- Page 11 and 12:
Corelaţii clinice,imunohistochimic
- Page 13 and 14:
Corelaţii clinice,imunohistochimic
- Page 15 and 16:
Corelaţii clinice,imunohistochimic
- Page 17 and 18:
Corelaţii clinice,imunohistochimic
- Page 19 and 20:
Corelaţii clinice,imunohistochimic
- Page 21 and 22:
Corelaţii clinice,imunohistochimic
- Page 23 and 24:
Corelaţii clinice,imunohistochimic
- Page 25 and 26:
Corelaţii clinice,imunohistochimic
- Page 27 and 28:
Corelaţii clinice,imunohistochimic
- Page 29 and 30: Corelaţii clinice,imunohistochimic
- Page 31 and 32: Corelaţii clinice,imunohistochimic
- Page 33 and 34: Corelaţii clinice,imunohistochimic
- Page 35 and 36: Corelaţii clinice,imunohistochimic
- Page 37 and 38: Corelaţii clinice,imunohistochimic
- Page 39 and 40: Corelaţii clinice,imunohistochimic
- Page 41 and 42: Corelaţii clinice,imunohistochimic
- Page 43 and 44: Corelaţii clinice,imunohistochimic
- Page 45 and 46: Corelaţii clinice,imunohistochimic
- Page 47 and 48: Corelaţii clinice,imunohistochimic
- Page 49 and 50: Corelaţii clinice,imunohistochimic
- Page 51 and 52: Corelaţii clinice,imunohistochimic
- Page 53 and 54: Corelaţii clinice,imunohistochimic
- Page 55 and 56: Corelaţii clinice,imunohistochimic
- Page 57 and 58: Corelaţii clinice,imunohistochimic
- Page 59 and 60: Corelaţii clinice,imunohistochimic
- Page 61 and 62: Corelaţii clinice,imunohistochimic
- Page 63 and 64: Corelaţii clinice,imunohistochimic
- Page 65 and 66: Corelaţii clinice,imunohistochimic
- Page 67 and 68: Corelaţii clinice,imunohistochimic
- Page 69 and 70: Corelaţii clinice,imunohistochimic
- Page 71 and 72: Corelaţii clinice,imunohistochimic
- Page 73 and 74: Corelaţii clinice,imunohistochimic
- Page 75 and 76: Corelaţii clinice,imunohistochimic
- Page 77 and 78: Corelaţii clinice,imunohistochimic
- Page 79: Corelaţii clinice,imunohistochimic